Ria Kakkad (Drug Target Review)2023-04-18T14:00:55
Using rodent models, the researchers emphasized the potential of newly generated neurons in adulthood to serve as therapy for addressing the functional deficits and pathology associated with Alzheimer's disease.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-11-13T07:00:00Z
Contributor Dr Panos Roussos, Drug Target Review
2026-11-10T13:56:00Z
2024-05-07T13:11:19
Sponsored by BellBrook Labs
2024-01-10T08:23:16
Sponsored by BellBrook Labs
2023-05-23T11:10:47
Sponsored by NanoTemper Technologies
2023-04-04T15:03:09
Sponsored by Agilent
2023-12-11T10:49:07
Sponsored by Leica Microsystems
2025-11-19T16:00:00
Sponsored by Eurofins DiscoverX
Site powered by Webvision Cloud